Suppr超能文献

血糖控制与糖尿病患者骨折风险的关系:一项巢式病例对照研究。

Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.

机构信息

Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel, Switzerland.

Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.

出版信息

J Clin Endocrinol Metab. 2019 May 1;104(5):1645-1654. doi: 10.1210/jc.2018-01879.

Abstract

CONTEXT

Diabetes mellitus (DM) has been associated with an increased risk of fractures. However, the effect of glycemic control on the risk of fracture is not well understood.

OBJECTIVE

To evaluate the association between glycemic control and the risk of low-trauma fractures in patients with type 1 DM (T1DM) and type 2 DM (T2DM).

DESIGN

Nested case-control analysis.

SETTING

UK-based Clinical Practice Research Datalink.

PATIENTS OR OTHER PARTICIPANTS

The study population was patients whose T1DM or T2DM had been newly diagnosed between 1995 and 2015. The cases were patients with a low-trauma fracture after DM onset. We matched four controls to each case by age, sex, general practice, fracture date, and DM type and duration.

STATISTICAL ANALYSIS

Conditional logistic regression analyses were performed, adjusted for covariates, including body mass index, smoking, DM complications and medications.

RESULTS

The study population included 3329 patients with T1DM and 44,275 patients with T2DM. The median duration between DM onset and fracture date was 4.5 years for both T1DM and T2DM. The risk of fracture was increased in the patients with T1DM with a mean hemoglobin A1c >8.0% (adjusted OR, 1.39; 95% CI, 1.06 to 1.83) compared with those patients with T1DM and a mean hemoglobin A1c ≤7.0%. No such effect was found in the patients with T2DM. Independently of glycemic control, the risk of fracture was elevated in patients with T2DM and the current use of rosiglitazone and pioglitazone.

CONCLUSIONS

The effect of glycemic control on the risk of low-trauma fracture differs between patients with T1DM and T2DM. Poor glycemic control increased the risk of fractures in patients with T1DM but not in those with T2DM.

摘要

背景

糖尿病(DM)与骨折风险增加相关。然而,血糖控制对骨折风险的影响尚不清楚。

目的

评估 1 型糖尿病(T1DM)和 2 型糖尿病(T2DM)患者血糖控制与低创伤性骨折风险之间的关系。

设计

巢式病例对照分析。

设置

英国基于临床实践研究数据链接。

患者或其他参与者

研究人群为 1995 年至 2015 年间新诊断为 T1DM 或 T2DM 的患者。病例为 DM 发病后发生低创伤性骨折的患者。我们按年龄、性别、全科医生、骨折日期和 DM 类型和持续时间,为每个病例匹配了 4 名对照。

统计分析

进行条件逻辑回归分析,调整了包括体重指数、吸烟、DM 并发症和药物在内的混杂因素。

结果

研究人群包括 3329 例 T1DM 患者和 44275 例 T2DM 患者。T1DM 和 T2DM 从 DM 发病到骨折日期的中位时间分别为 4.5 年。T1DM 患者中,糖化血红蛋白(HbA1c)均值>8.0%的患者骨折风险增加(校正比值比,1.39;95%CI,1.06 至 1.83),而 HbA1c 均值≤7.0%的患者则没有这种效果。在 T2DM 患者中,没有发现这种效果。独立于血糖控制,T2DM 患者当前使用罗格列酮和吡格列酮会增加骨折风险。

结论

血糖控制对 T1DM 和 T2DM 患者低创伤性骨折风险的影响不同。血糖控制不佳会增加 T1DM 患者的骨折风险,但不会增加 T2DM 患者的骨折风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验